10 things you need to know today: May 2, 2020

FDA approves emergency use of remdesivir for COVID-19 treatment, Fauci blocked from testifying before House committee, and more

Gilead.
(Image credit: JOSH EDELSON/AFP via Getty Images)

1. FDA approves emergency use of remdesivir for COVID-19 treatment

The Food and Drug Administration on Friday authorized the emergency use of the antiviral remdesivir on COVID-19 patients. Gilead Sciences revealed promising study results involving remdesivir on Wednesday, and the Trump administration announced the authorization, which sidesteps the usual testing required to approve a drug's usage, during a Friday Oval Office meeting between President Trump, Health and Human Services Secretary Alexander Azar, FDA commissioner Dr. Stephen Hahn, and Gilead Sciences CEO Daniel O'Day. In Gilead's trial, at least 50 percent of patients treated with remdesivir improved, though the study wasn't evaluated against a control group, and it's unclear if those recoveries were natural. As clinical trials continue, doctors can use remdesivir on some patients. O'Day said Gilead is working to rapidly increase its supply.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
To continue reading this article...
Continue reading this article and get limited website access each month.
Get unlimited website access, exclusive newsletters plus much more.
Cancel or pause at any time.
Already a subscriber to The Week?
Not sure which email you used for your subscription? Contact us
Tim O'Donnell

Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.